{"id":3041,"date":"2026-10-27T15:18:16","date_gmt":"2026-10-27T15:18:16","guid":{"rendered":"https:\/\/amercanfirstfinance.com\/?p=3041"},"modified":"2026-10-27T15:18:16","modified_gmt":"2026-10-27T15:18:16","slug":"millions-of-medicare-beneficiaries-face-plan-terminations-and-coverage-changes-for-2027","status":"publish","type":"post","link":"https:\/\/amercanfirstfinance.com\/?p=3041","title":{"rendered":"Millions of Medicare Beneficiaries Face Plan Terminations and Coverage Changes for 2027"},"content":{"rendered":"<p>The private Medicare landscape is undergoing a significant shake-up, leaving millions of older Americans and individuals with disabilities scrambling to review their healthcare and prescription drug coverage ahead of the annual open enrollment period. According to a new analysis of federal plan data from the Centers for Medicare &amp; Medicaid Services (CMS), a staggering 4.3 million Medicare beneficiaries will find their current private plans terminated at the end of 2026. This total includes 3.1 million enrollees in Medicare Advantage drug plans and 1.2 million participants in stand-alone prescription drug plans.<\/p>\n<p>The market for private Medicare options\u2014encompassing Medicare Advantage and Part D stand-alone prescription drug plans\u2014has always been dynamic, with offerings shifting year after year. However, the sheer scale of the upcoming disruptions for 2027 has heightened anxiety among policy experts and beneficiaries alike. Leading up to the official start of the Medicare annual open enrollment period on October 15, numerous health insurers announced they would be scaling back their footprints, reducing the number of Medicare Advantage plans available in various regions. <\/p>\n<p>Compounding this instability was widespread uncertainty regarding premiums and plan availability in the stand-alone prescription drug plan market. These jitters followed the Trump administration\u2019s decision to end the Part D Premium Stabilization Demonstration one year ahead of schedule, a move that analysts warned could trigger larger-than-average premium increases for vulnerable beneficiaries. <\/p>\n<p>The latest data paints a stark picture of the fallout. Out of the 4.3 million total individuals facing the termination of their coverage, private insurers will pull the plug on Medicare Advantage prescription drug plans (MA-PDs) for approximately 3.1 million people on December 31. The vast majority of these affected beneficiaries\u2014some 2.8 million individuals\u2014are enrolled in MA-PDs that are available for general public enrollment. An additional 300,000 people are enrolled in Medicare Advantage special needs plans (SNPs), which strictly limit enrollment to individuals who are dually eligible for both Medicare and Medicaid, or those who live with specific, qualifying health needs.<\/p>\n<p>For the 2.8 million individual enrollees whose MA-PDs are being dismantled, the road ahead requires proactive decision-making. These beneficiaries must actively select and enroll in another Medicare Advantage plan if one is available in their local geographic area. If they fail to take action by the end of the enrollment window, they will be automatically switched over to traditional Medicare. <\/p>\n<p>The affected population of individual MA-PD enrollees represents roughly 14% of all enrollees in plans open for general enrollment. This proportion is broadly comparable to the 13% affected by similar terminations going into the 2026 plan year, but it remains substantially higher than the rates seen in previous years. Meanwhile, among enrollees in special needs plans, roughly 4% will face a plan termination for 2027, though historical trend data for SNP terminations has not been previously tracked in the same detail by organizations like KFF.<\/p>\n<p>A closer look at the data reveals that the disruption is heavily concentrated among a handful of major healthcare companies. Just four parent organizations are responsible for terminating plans that account for half of all individual enrollees losing their MA-PD coverage. Humana, Inc. leads the list, accounting for 19% of affected enrollees, or approximately 530,000 people. UnitedHealth Group follows at 13%, representing about 367,000 enrollees. CVS Health Corporation accounts for 9% or 254,000 enrollees, and Aware Integrated, Inc.\u2014which operates Blue Cross branded plans in Minnesota\u2014also accounts for 9% or 249,000 enrollees.<\/p>\n<p>There is a silver lining for beneficiaries who see their Medicare Advantage coverage involuntarily terminated: they qualify for a special enrollment period for Medigap policies backed by guaranteed issue rights. This crucial protection means that insurance companies cannot legally deny these beneficiaries a Medigap policy or charge them higher premiums because of a pre-existing medical condition. Medigap serves as vital supplemental insurance that helps cover out-of-pocket costs, such as copayments and deductibles, which are left unpaid by traditional Medicare.<\/p>\n<h2>Stand-Alone Drug Plan Terminations and Consolidation Waves<\/h2>\n<p>The turbulence is not restricted to Medicare Advantage. Approximately 1.2 million enrollees in stand-alone prescription drug plans (PDPs) will also see their coverage terminated at the conclusion of the year. This figure translates to roughly 6% of all PDP enrollees nationwide, representing a doubling of the share impacted compared to the previous year, when only 3% faced similar terminations.<\/p>\n<p>The vast majority of these affected PDP enrollees\u201481%, or about 950,000 people\u2014are currently enrolled in the SilverScript Choice PDP sponsored by CVS Health, which is being canceled across 13 distinct PDP regions for 2027. Another 190,000 enrollees, or 16% of the total, are enrolled in HealthSpring Extra Rx, a plan sponsored by the Health Care Service Corporation that is slated for termination in 16 regions. The remaining 3% of affected PDP enrollees are distributed across smaller regional plans: roughly 14,000 are in the BlueCross Rx Value plan in South Carolina, while 7,000 are in Blue Rx PDP Complete and another 7,000 are in Blue Rx PDP Plus, both of which operate in Pennsylvania and West Virginia.<\/p>\n<p>These widespread PDP terminations have directly contributed to a shrinkage in overall market choice. The average Medicare beneficiary will find a reduced selection of stand-alone drug plans, dropping to just 9 choices in 2027 from 11 choices in 2026. This more concentrated enrollment pool means a smaller number of plans command larger shares of the market, potentially exposing a greater number of beneficiaries to recurring annual enrollment disruptions as plan availability and pricing fluctuate from year to year. <\/p>\n<figure class=\"article-inline-figure\"><img decoding=\"async\" src=\"https:\/\/www.kff.org\/wp-content\/uploads\/sites\/7\/2026\/10\/more-than-4-million-medicare-beneficiaries-will-have-their-medicare-advantage-or-stand-alone-prescription-drug-plan-terminated-on-december-31.png\" alt=\"More Than 4 Million Medicare Beneficiaries Will Have Their Medicare Advantage or Stand-Alone Prescription Drug Plan Terminated at the End of 2026\" class=\"article-inline-img\" loading=\"lazy\" \/><\/figure>\n<p>Enrollees whose PDPs are being terminated must select a new stand-alone prescription drug plan to supplement traditional Medicare if they want to retain drug coverage, or alternatively, they can transition to a Medicare Advantage plan that includes prescription drug benefits.<\/p>\n<p>Beyond outright terminations, another 1.4 million Medicare Advantage enrollees find themselves swept up in corporate consolidations, where their current plan is being merged with another plan offered by the same insurer. This group includes 500,000 Medicare Advantage enrollees in plans available for general enrollment and roughly 900,000 enrollees housed within special needs plans.<\/p>\n<p>These structural shifts are partially driven by new regulatory requirements. Beginning in January 2027, private insurers that manage both a dual eligible special needs plan (D-SNP) and an affiliated Medicaid managed care plan within the same county are generally restricted to offering only one D-SNP for full-benefit dual-eligible individuals. In response to this federal mandate, private insurance companies have introduced a sweeping wave of modifications and consolidations across their D-SNP portfolios for the upcoming year.<\/p>\n<p>Beneficiaries who are automatically transitioned to a different Medicare Advantage plan due to a consolidation retain the freedom to select a completely different Medicare Advantage plan during the open enrollment window. Dual-eligible individuals also retain certain permissions to switch plans at other points throughout the year under specific circumstances. <\/p>\n<p>While these consolidated enrollees can technically opt to switch to traditional Medicare, they do not automatically receive federal guaranteed issue rights if they wish to purchase a Medigap policy. However, policy experts note that the absence of federal guaranteed issue rights for Medigap is generally less consequential for dual-eligible individuals. Because state Medicaid programs routinely cover Medicare premiums and, in many cases, cost-sharing expenses for dual-eligible beneficiaries, these individuals typically have less need for additional commercial supplemental coverage.<\/p>\n<h2>Navigating the Annual Open Enrollment Period<\/h2>\n<p>As the annual open enrollment period moves forward, it provides Medicare beneficiaries with a critical window to thoroughly review their current healthcare and drug coverage options and make adjustments where necessary. Even for the millions of beneficiaries whose private plans are not being terminated or consolidated, the upcoming year will likely bring notable adjustments. Continuing plans often feature shifting costs, altered benefits, modified provider networks, and revised drug formularies.<\/p>\n<p>For participants in stand-alone prescription drug plans, remaining in a current plan without checking for updates could prove costly. Some beneficiaries who stay put face the prospect of sizeable premium increases for 2027, making a careful comparison of available plan alternatives a financial necessity. <\/p>\n<p>Comparing coverage options remains a formidable challenge for many older adults, however. The typical Medicare beneficiary must navigate a complex field of choices, weighing an average of 28 Medicare Advantage prescription drug plan options and 9 stand-alone prescription drug plan options as they determine the best path forward for their healthcare needs.<\/p>\n<h2>Methods<\/h2>\n<p>The data examined in this analysis encompasses Medicare Advantage prescription drug plans available for general enrollment as well as special needs plans. It intentionally excludes employer- and union-sponsored plans, Medicare Advantage plans that do not offer prescription drug coverage, cost plans, PACE plans, and HCPPs. The analysis also incorporates stand-alone prescription drug plans available to beneficiaries enrolled in traditional Medicare. <\/p>\n<p>Plan terminations tracked in this analysis capture county-level plan offerings that recorded at least 11 active enrollees in June 2026 but are no longer available for enrollment for the 2027 plan year. This criteria accounts for plans that were entirely non-renewed by insurers, as well as those that trimmed their geographic service areas to drop coverage in a subset of counties, including consolidations that simultaneously reduced service footprints. These shifts are identified using the official 2027 Part C and Part D plan crosswalk data.<\/p>\n<p>Individuals enrolled in plans classified as a renewal plan in the 2027 Part C and D plan crosswalk, but which happen to feature a different plan identification number for 2027, are excluded from the total count of people affected by terminations. Similarly, individuals enrolled in plans undergoing consolidation with another plan offered by the same insurer are not categorized as being in terminated plans. This distinction is made because these enrollees will maintain continuous coverage under Medicare Advantage unless they take proactive steps to switch to traditional Medicare, and these specific enrollees likewise do not receive federal guaranteed issue rights for Medigap policies.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>The private Medicare landscape is undergoing a significant shake-up, leaving millions of older Americans and individuals with disabilities scrambling to review their healthcare and prescription drug coverage ahead of the annual open enrollment period. According to a new analysis of federal plan data from the Centers for Medicare &amp; Medicaid Services (CMS), a staggering 4.3 [&hellip;]<\/p>\n","protected":false},"author":21,"featured_media":3040,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[461],"tags":[3652,739,164,867,464,462,162,463,735,1436,139,3653],"class_list":["post-3041","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-healthcare-and-medical-costs","tag-beneficiaries","tag-changes","tag-coverage","tag-face","tag-health-policy","tag-healthcare","tag-insurance","tag-medical-costs","tag-medicare","tag-millions","tag-plan","tag-terminations"],"_links":{"self":[{"href":"https:\/\/amercanfirstfinance.com\/index.php?rest_route=\/wp\/v2\/posts\/3041","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/amercanfirstfinance.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/amercanfirstfinance.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/amercanfirstfinance.com\/index.php?rest_route=\/wp\/v2\/users\/21"}],"replies":[{"embeddable":true,"href":"https:\/\/amercanfirstfinance.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=3041"}],"version-history":[{"count":0,"href":"https:\/\/amercanfirstfinance.com\/index.php?rest_route=\/wp\/v2\/posts\/3041\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/amercanfirstfinance.com\/index.php?rest_route=\/wp\/v2\/media\/3040"}],"wp:attachment":[{"href":"https:\/\/amercanfirstfinance.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=3041"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/amercanfirstfinance.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=3041"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/amercanfirstfinance.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=3041"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}